4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Epitomee Medical Ltd (EPIT) operates in the Medical Devices industry and is headquartered in Caesarea, Israel with about 44 employees. Its market capitalization is roughly ₪87 million. In the fiscal year ended 2025-12-31, EPIT reported $0M in revenue and ($9M) in net income.
Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel. The company offers capsules for the treatment of overweight and obesity. It also focuses on developing biologic drug delivery solutions. Epitomee Medical Ltd was incorporated in 2005 and is based in Caesarea, Israel.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $10M | $0M | — |
| Gross Profit | ($1M) | $0M | — | — | — |
| Operating Income (EBIT) | ($10M) | ($9M) | $0M | ($11M) | — |
| Net Income | ($9M) | ($2M) | ($6M) | ($15M) | — |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $33M | $40M | $40M | $55M | — |
| Total Liabilities | $7M | $6M | $6M | $16M | — |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EPIT viewer.
This page in other languages: עברית
About TickerBase · Data methodology & sources · Privacy · Terms